Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. Exaprolol - Wikipedia
Exaprolol - Wikipedia
From Wikipedia, the free encyclopedia
Exaprolol
Names
IUPAC name
1-(2-Cyclohexylphenoxy)-3-(propan-2-ylamino)propan-2-ol
Other names
Esprolol
Identifiers
CAS Number
  • 55837-19-9 checkY
3D model (JSmol)
  • Interactive image
ChemSpider
  • 58934
KEGG
  • D04120
PubChem CID
  • 65485
UNII
  • Q4XX54I93R checkY
CompTox Dashboard (EPA)
  • DTXSID20866509 Edit this at Wikidata
InChI
  • InChI=1S/C18H29NO2/c1-14(2)19-12-16(20)13-21-18-11-7-6-10-17(18)15-8-4-3-5-9-15/h6-7,10-11,14-16,19-20H,3-5,8-9,12-13H2,1-2H3
    Key: ABXHHEZNIJUQFM-UHFFFAOYSA-N
SMILES
  • CC(C)NCC(COC1=CC=CC=C1C2CCCCC2)O
Properties
Chemical formula
C18H29NO2
Molar mass 291.435 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Chemical compound

Exaprolol is a beta-adrenoceptor antagonist.[1]

Synthesis

[edit]
Exaprolol synthesis[2]

References

[edit]
  1. ^ Van Waarde, A; Doorduin, J; De Jong, JR; Dierckx, RA; Elsinga, PH (2008). "Synthesis and preliminary evaluation of (S)-11C-exaprolol, a novel beta-adrenoceptor ligand for PET". Neurochemistry International. 52 (4–5): 729–33. doi:10.1016/j.neuint.2007.09.009. PMID 17961850.
  2. ^ Carissimi, M; Gentili, P; Grumelli, E; Milla, E; Picciola, G; Ravenna, F (1976). "Basic ethers of cyclohexylphenols with beta-blocking activity: Synthesis and pharmacological study of exaprolol". Arzneimittel-Forschung. 26 (4): 506–16. PMID 8056.


  • v
  • t
  • e
Adrenergic receptor modulators
α1
Agonists
  • 6-FNE
  • Amidephrine
  • Buspirone
  • Cirazoline
  • Corbadrine
  • Deoxyepinephrine (epinine, N-methyldopamine)
  • Desglymidodrine
  • Dexisometheptene
  • Dipivefrine
  • Dopamine
  • Droxidopa (L-DOPS)
  • Epinephrine
  • Etilefrine
  • Etilevodopa
  • Ethylnorepinephrine
  • Ibopamine
  • Indanidine
  • Isometheptene
  • L-DOPA (levodopa)
  • L-Phenylalanine
  • L-Tyrosine
  • Melevodopa
  • Metaraminol
  • Methoxamine
  • Methyldopa
  • Midodrine
  • Naphazoline
  • Norepinephrine
  • Octopamine
  • Oxymetazoline
  • Phenylephrine
  • Phenylpropanolamine
  • Synephrine
  • Tetryzoline
  • Tiamenidine
  • XP21279
  • Xylometazoline
Antagonists
  • Abanoquil
  • ADRIANA
  • Ajmalicine
  • Alfuzosin
  • Anisodamine
  • Anisodine
  • Atiprosin
  • Atypical antipsychotics (e.g., brexpiprazole, clozapine, olanzapine, quetiapine, risperidone)
  • Benoxathian
  • Beta blockers (e.g., adimolol, amosulalol, arotinolol, carvedilol, eugenodilol, labetalol)
  • Buflomedil
  • Bunazosin
  • Butanserin
  • Corynanthine
  • Dapiprazole
  • Domesticine
  • Doxazosin
  • Ergolines (e.g., acetergamine, ergotamine, dihydroergotamine, lisuride, nicergoline, terguride)
  • Etoperidone
  • Fenspiride
  • Hydroxyzine
  • Indoramin
  • Ketanserin
  • L-765,314
  • mCPP
  • Mepiprazole
  • Metazosin
  • Monatepil
  • Moxisylyte
  • MT-1207
  • Naftopidil
  • Nantenine
  • Neldazosin
  • Niaprazine
  • Niguldipine
  • Pardoprunox
  • Pelanserin
  • Perlapine
  • Phendioxan
  • Phenoxybenzamine
  • Phentolamine
  • Phenylpiperazine antidepressants (e.g., hydroxynefazodone, nefazodone, trazodone, triazoledione)
  • Piperoxan
  • Prazosin
  • Quinazosin
  • Quinidine
  • Silodosin
  • Spegatrine
  • Spiperone
  • Talipexole
  • Tamsulosin
  • Terazosin
  • Tiodazosin
  • Tolazoline
  • Tetracyclic antidepressants (e.g., amoxapine, maprotiline, mianserin)
  • Tricyclic antidepressants (e.g., amitriptyline, clomipramine, doxepin, imipramine, trimipramine)
  • Trimazosin
  • Typical antipsychotics (e.g., chlorpromazine, fluphenazine, loxapine, thioridazine)
  • Urapidil
  • WB-4101
  • Zolertine
α2
Agonists
  • (R)-3-Nitrobiphenyline
  • 4-NEMD
  • 6-FNE
  • Amitraz
  • Apraclonidine
  • Brimonidine
  • CHF-1024
  • Clonidine
  • Corbadrine
  • Deoxyepinephrine (epinine, N-methyldopamine)
  • Detomidine
  • Dexmedetomidine
  • Dihydroergotamine
  • Dipivefrine
  • Dopamine
  • Droxidopa (L-DOPS)
  • Etilevodopa
  • Ergotamine
  • Epinephrine
  • Etilefrine
  • Ethylnorepinephrine
  • Guanabenz
  • Guanfacine
  • Guanoxabenz
  • L-DOPA (levodopa)
  • L-Phenylalanine
  • L-Tyrosine
  • Ibopamine
  • Lofexidine
  • Medetomidine
  • Melevodopa
  • Methyldopa
  • Mivazerol
  • Moxonidine
  • Naphazoline
  • Nolomirole
  • Norepinephrine
  • Oxymetazoline
  • Phenylpropanolamine
  • Piperoxan
  • PS75
  • Rezatomidine
  • Rilmenidine
  • Romifidine
  • Talipexole
  • Tasipimidine
  • Tetryzoline
  • Tiamenidine
  • Tizanidine
  • Tolonidine
  • Urapidil
  • Vatinoxan
  • XP21279
  • Xylazine
  • Xylometazoline
Antagonists
  • 1-PP
  • Adimolol
  • Amesergide
  • Aptazapine
  • Atipamezole
  • Atypical antipsychotics (e.g., asenapine, brexpiprazole, clozapine, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, zotepine)
  • Azapirones (e.g., buspirone, gepirone, ipsapirone, tandospirone)
  • BRL-44408
  • Buflomedil
  • Cirazoline
  • Efaroxan
  • Esmirtazapine
  • Fenmetozole
  • Fipamezole
  • Fluparoxan
  • Idazoxan
  • Ketanserin
  • Lisuride
  • mCPP
  • Mianserin
  • Mirtazapine
  • NAN-190
  • Pardoprunox
  • Phentolamine
  • Phenoxybenzamine
  • Piperoxan
  • Piribedil
  • Rauwolscine
  • Rotigotine
  • Setiptiline
  • Spegatrine
  • Spiroxatrine
  • Sunepitron
  • Terguride
  • Tolazoline
  • Typical antipsychotics (e.g., chlorpromazine, fluphenazine, loxapine, thioridazine)
  • Yohimbine
β
Agonists
  • Abediterol
  • Alifedrine
  • Amibegron
  • Arbutamine
  • Arformoterol
  • Arotinolol
  • BAAM
  • Bambuterol
  • Befunolol
  • Bitolterol
  • Broxaterol
  • Buphenine
  • Butopamine
  • Carbuterol
  • Carmoterol
  • Cimaterol
  • Clenbuterol
  • Colterol
  • Corbadrine
  • Denopamine
  • Deoxyepinephrine (epinine, N-methyldopamine)
  • Dipivefrine
  • Dobutamine
  • Dopamine
  • Dopexamine
  • Droxidopa (L-DOPS)
  • Epinephrine
  • Etafedrine
  • Etilefrine
  • Etilevodopa
  • Ethylnorepinephrine
  • Eugenodilol
  • Fenoterol
  • Formoterol
  • Hexoprenaline
  • Higenamine
  • Ibopamine
  • Indacaterol
  • Isoetarine
  • Isoprenaline
  • Isoxsuprine
  • L-DOPA (levodopa)
  • L-Phenylalanine
  • L-Tyrosine
  • Levosalbutamol
  • Lubabegron
  • Mabuterol
  • Melevodopa
  • Methoxyphenamine
  • Methyldopa
  • Mirabegron
  • Norepinephrine
  • Orciprenaline
  • Oxyfedrine
  • PF-610355
  • Phenylpropanolamine
  • Pirbuterol
  • Prenalterol
  • Ractopamine
  • Procaterol
  • Reproterol
  • Rimiterol
  • Ritodrine
  • Salbutamol
  • Salmeterol
  • Solabegron
  • Terbutaline
  • Tretoquinol
  • Tulobuterol
  • Vibegron
  • Vilanterol
  • Xamoterol
  • XP21279
  • Zilpaterol
  • Zinterol
Antagonists
  • Acebutolol
  • Adaprolol
  • Adimolol
  • Afurolol
  • Alprenolol
  • Alprenoxime
  • Amosulalol
  • Ancarolol
  • Arnolol
  • Arotinolol
  • Atenolol
  • Befunolol
  • Betaxolol
  • Bevantolol
  • Bisoprolol
  • Bopindolol
  • Bornaprolol
  • Brefonalol
  • Bucindolol
  • Bucumolol
  • Bufetolol
  • Bufuralol
  • Bunitrolol
  • Bunolol
  • Bupranolol
  • Butaxamine
  • Butidrine
  • Butofilolol
  • Capsinolol
  • Carazolol
  • Carpindolol
  • Carteolol
  • Carvedilol
  • Celiprolol
  • Cetamolol
  • Cicloprolol
  • Cinamolol
  • Cloranolol
  • Cyanopindolol
  • Dalbraminol
  • Dexpropranolol
  • Diacetolol
  • Dichloroisoprenaline
  • Dihydroalprenolol
  • Dilevalol
  • Diprafenone
  • Draquinolol
  • Ecastolol
  • Epanolol
  • Ericolol
  • Ersentilide
  • Esatenolol
  • Esprolol
  • Eugenodilol
  • Exaprolol
  • Falintolol
  • Flestolol
  • Flusoxolol
  • Hydroxycarteolol
  • Hydroxytertatolol
  • ICI-118,551
  • Idropranolol
  • Indenolol
  • Indopanolol
  • Iodocyanopindolol
  • Iprocrolol
  • Isoxaprolol
  • Isamoltane
  • Labetalol
  • Landiolol
  • Levobetaxolol
  • Levobunolol
  • Levomoprolol
  • Medroxalol
  • Mepindolol
  • Metipranolol
  • Metoprolol
  • Moprolol
  • Nadolol
  • Nadoxolol
  • Nebivolol
  • Nifenalol
  • Nipradilol
  • Oxprenolol
  • Pacrinolol
  • Pafenolol
  • Pamatolol
  • Pargolol
  • Penbutolol
  • Pindolol
  • Practolol
  • Primidolol
  • Procinolol
  • Pronethalol
  • Propafenone
  • Propranolol
  • Ridazolol
  • Ronactolol
  • Soquinolol
  • Sotalol
  • Spirendolol
  • SR 59230A
  • Sulfinalol
  • Talinolol
  • Tazolol
  • Tertatolol
  • Tienoxolol
  • Tilisolol
  • Timolol
  • Tiprenolol
  • Tolamolol
  • Toliprolol
  • Xibenolol
  • Xipranolol
  • See also: Receptor/signaling modulators
  • Dopaminergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://teknopedia.ac.id/w/index.php?title=Exaprolol&oldid=1330817380"
Categories:
  • Beta blockers
  • N-isopropyl-phenoxypropanolamines
  • Cyclohexyl compounds
  • Cardiovascular system drug stubs
Hidden categories:
  • Articles without EBI source
  • Articles containing unverified chemical infoboxes
  • Chembox image size set
  • Articles with short description
  • Short description matches Wikidata
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id